IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial. - Bunse L; Lindner K; Wick A; Freitag A; Lanz LM; Edelmann D; Suwala A; Breckwoldt MO; Harting I; Sahm F; Schlenk RF; Schmitt A; et al. (Nature cancer, 2026)